Julian Arbuckle

Co-Founder & Chief Business Officer at Black Swan Pharmaceuticals

Julian Arbuckle has worked in the life sciences sector for over 25 years and has significant knowledge of the research and development process gained by working within both blue-chip pharmaceutical and start-up biotechnology companies.

During his time in the industry he has gained significant experience in leading drug development programs and providing specialist scientific consulting advice to sponsors working on long-term prevention trials in the CNS disease area. He has also initiated, and led, several industry/academic collaborations working primarily in the field of precision medicine. Julian also extensive experience of business development, alliance management and commercial aspects of the drug development business.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Black Swan Pharmaceuticals

Black Swan Pharmaceuticals (BSP) is dedicated to discovering innovative gene targeting therapeutics for Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders.


Industries

Employees

1-10

Links